The transcriptomic landscape and directed chemical interrogation of MLL-rearranged acute myeloid leukemias
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The transcriptomic landscape and directed chemical interrogation of MLL-rearranged acute myeloid leukemias
Authors
Keywords
-
Journal
NATURE GENETICS
Volume 47, Issue 9, Pages 1030-1037
Publisher
Springer Nature
Online
2015-08-04
DOI
10.1038/ng.3371
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- MLL partial tandem duplication leukemia cells are sensitive to small molecule DOT1L inhibition
- (2015) M. W. M. Kuhn et al. HAEMATOLOGICA
- The landscape of somatic mutations in infant MLL-rearranged acute lymphoblastic leukemias
- (2015) Anna K Andersson et al. NATURE GENETICS
- MLL partial tandem duplication leukemia cells are sensitive to small molecule DOT1L inhibition
- (2015) M. W. M. Kuhn et al. HAEMATOLOGICA
- EVI1-rearranged acute myeloid leukemias are characterized by distinct molecular alterations
- (2014) Vincent-Philippe Lavallée et al. BLOOD
- Preclinical efficacy of MEK inhibition in Nras-mutant AML
- (2014) M. R. Burgess et al. BLOOD
- Ras pathway mutations are prevalent in relapsed childhood acute lymphoblastic leukemia and confer sensitivity to MEK inhibition
- (2014) J. Irving et al. BLOOD
- Synergistic antiproliferative and anticholesterogenic effects of linalool, 1,8-cineole, and simvastatin on human cell lines
- (2014) Boris Rodenak Kladniew et al. CHEMICO-BIOLOGICAL INTERACTIONS
- PU.1 is essential for MLL leukemia partially via crosstalk with the MEIS/HOX pathway
- (2014) J Zhou et al. LEUKEMIA
- Dual PI3K/mTOR inhibition shows antileukemic activity in MLL-rearranged acute myeloid leukemia
- (2014) N Sandhöfer et al. LEUKEMIA
- Identification of small molecules that support human leukemia stem cell activity ex vivo
- (2014) Caroline Pabst et al. NATURE METHODS
- Pyrimidoindole derivatives are agonists of human hematopoietic stem cell self-renewal
- (2014) I. Fares et al. SCIENCE
- Phase II Study of the Oral MEK Inhibitor Selumetinib in Advanced Acute Myelogenous Leukemia: A University of Chicago Phase II Consortium Trial
- (2013) N. Jain et al. CLINICAL CANCER RESEARCH
- Insights in dynamic kinome reprogramming as a consequence of MEK inhibition in MLL-rearranged AML
- (2013) K R Kampen et al. LEUKEMIA
- High incidence of RAS signalling pathway mutations in MLL-rearranged acute myeloid leukemia
- (2013) V Grossmann et al. LEUKEMIA
- The MLL recombinome of acute leukemias in 2013
- (2013) C Meyer et al. LEUKEMIA
- Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid Leukemia
- (2013) NEW ENGLAND JOURNAL OF MEDICINE
- A novel hierarchical prognostic model of AML solely based on molecular mutations
- (2012) V. Grossmann et al. BLOOD
- Deregulated Expression of EVI1 Defines a Poor Prognostic Subset of MLL-Rearranged Acute Myeloid Leukemias: A Study of the German-Austrian Acute Myeloid Leukemia Study Group and the Dutch-Belgian-Swiss HOVON/SAKK Cooperative Group
- (2012) Stefan Gröschel et al. JOURNAL OF CLINICAL ONCOLOGY
- Unresponsiveness of colon cancer to BRAF(V600E) inhibition through feedback activation of EGFR
- (2012) Anirudh Prahallad et al. NATURE
- Selective Killing of Mixed Lineage Leukemia Cells by a Potent Small-Molecule DOT1L Inhibitor
- (2011) Scott R. Daigle et al. CANCER CELL
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now